References
- Anderson R, Jonsson R, Tarkowski A, Bengtsson B Å, Malm-vall B E. T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis. Ann Rheum Dis 1987; 46: 915–23
- Rubin L R. The soluble interleukin-2 receptor in rheumatic disease (editorial). Arthritis Rheum 1990; 33: 1145–8
- Franzén P, Sutinen S, vonKnorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemi-ologic, clinical and pathologic study, 1984–1988. J Rheumatol 1992; 19: 273–6
- Campen D H, Horwitz D A, Quismorio F P, Jr, Ehresmann G R, Martin W J. Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum 1988; 31: 1358–64
- Rubin L A, Snow K M, Kurman C C, Nelson D L, Keystone E C. Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity. J Rheumatol 1990; 17: 597–602
- Wong K L, Wong R PO. Serum soluble interleukin 2 receptor in systemic lupus erythematosus: effects of disease activity and infection. Ann Rheum Dis 1991; 50: 706–9
- Salvarani C, Macchioni P, Boiardi L, Rossi F, Maldini M C, Mancini R, et al. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations. J Rheumatol 1992; 19: 1100–6
- Wolf R E, Brelsford W G, Hall V C, Adams S B. Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis. J Rheumatol 1992; 19: 524–8
- Parrish R W, Williams J D, Davies B H. Serum beta-2-microglo-bulin and angiotensin-converting enzyme activity in sarcoido-sis. Thorax 1982; 37: 936–40
- Riska H, Pettersson T, Froseth B, Klockars M. Beta2microglo-bulin in pleural effusions. Acta Med Scand 1982; 211: 45–50